Senseonics. has been granted a patent for a method of calibrating analyte sensors using reference measurements. The system involves calculating blood analyte levels from sensor data, updating conversion functions based on user-entered reference measurements, and wirelessly conveying results to a handheld display device. GlobalData’s report on Senseonics gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Senseonics Holdings Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Senseonics, Medical data analysis was a key innovation area identified from patents. Senseonics's grant share as of July 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.

Blood analyte monitoring and calibration system

Source: United States Patent and Trademark Office (USPTO). Credit: Senseonics Holdings Inc

The granted patent US12059255B2 outlines a method and system for monitoring blood analyte levels using a body-worn transceiver and an analyte sensor. The method involves calculating blood analyte levels based on interstitial fluid (ISF) analyte levels and their rates of change, utilizing a conversion function that incorporates analyte diffusion and consumption rates. The transceiver wirelessly conveys these calculated analyte levels to a handheld display device, which receives and displays the data. Additionally, the system allows users to input reference measurements and corresponding timestamps, which are used to update the conversion function, enhancing the accuracy of subsequent analyte level calculations.

The analyte monitoring system includes a body-worn transceiver and a handheld display device, both of which work in tandem with the analyte sensor. The sensor generates detectable properties indicative of analyte concentrations, which are processed to produce sensor data. The system is designed to facilitate real-time monitoring and adjustment of blood analyte levels, particularly useful for conditions such as diabetes where precise glucose monitoring is critical. The patent also specifies the use of light sources and photodetectors within the analyte sensor to enhance measurement accuracy, further supporting the system's efficacy in continuous health monitoring.

To know more about GlobalData’s detailed insights on Senseonics, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.